The quarter fell short of the market’s operating hurdle. Published expectations were roughly $22–23 million of revenue and about $0.20 of adjusted loss per share; Red Cat delivered $20.2 million of revenue and a $0.26 GAAP loss per share.
| $ in thousands, except per-share data | Q2 2026 | Q2 2025 | Market expectation |
|---|---|---|---|
| Revenue | $20,189 | $3,219 | ~$22,000–$23,000 |
| Gross profit | $3,260 | $375 | — |
| Gross margin | 16.1% | 11.7% | — |
| Operating loss | $(38,645) | $(12,647) | — |
| Net loss | $(35,259) | $(13,279) | — |
| Loss per share | $(0.26) | $(0.15) | ~$(0.20) |
| Adjusted EBITDA | $(31,838) | $(9,903) | — |
| Cash from operating activities, six months | $(78,749) | $(28,805) | — |
Revenue growth was substantial, but not enough to beat the bar. Sales increased more than sixfold year over year and rose about 31% sequentially from the first quarter, yet the result was approximately 10% below the published revenue expectation. The filing gives no quantified new guidance, only that management is “progressing toward” its revenue outlook, so it does not provide a clear upside reset. (Condensed Consolidated Statements of Operations; company outlook commentary)
Margins improved, but the cost structure still overwhelmed gross profit. Gross margin rose to 16.1% from 11.7%, consistent with better production economics, but gross profit of $3.3 million covered only a small fraction of $41.9 million in operating expenses. The operating loss more than tripled year over year, while adjusted EBITDA loss widened to $31.8 million from $9.9 million. (Condensed Consolidated Statements of Operations; Reconciliation of Non-GAAP adjusted EBITDA)
Liquidity is strong, but it was bought with heavy equity financing rather than operations. Cash reached $325.6 million, but six-month operating cash use accelerated to $78.7 million, with another $13.0 million spent on acquisitions and capital equipment. The balance was supported by $258.8 million of common-stock issuance, while weighted-average shares rose 50% year over year to 136.9 million, making dilution a material part of the funding story. (Condensed Consolidated Balance Sheets; Condensed Consolidated Statements of Cash Flows; Condensed Consolidated Statements of Operations)
The strategic milestones add longer-term support but do not offset the near-term miss. Advancing to Gauntlet II, completing the Quaze acquisition, entering international markets with Hellcat, and moving Blue Ops toward full-rate production expand the potential platform. However, these are milestone and opportunity statements—not disclosed orders, revenue commitments, or profitability improvements. Net versus expectations, the filing is strategically encouraging but financially weaker than the market was looking for.
Read the original 8-K on SEC EDGAR ↗